{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:09:11Z","timestamp":1784747351513,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20F20414"],"award-info":[{"award-number":["20F20414"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012630","name":"Life Science Foundation of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jid.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T06:17:28Z","timestamp":1632723448000},"page":"1040-1049.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["PHLDA3 Is an Important Downstream Mediator of p53 in Squamous Cell Carcinogenesis"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-5621","authenticated-orcid":false,"given":"Megumi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-1323","authenticated-orcid":false,"given":"Akane","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-1529","authenticated-orcid":false,"given":"Masaki","family":"Fukuyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-4100","authenticated-orcid":false,"given":"Kiyono","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-3125","authenticated-orcid":false,"given":"Kazuhiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-3635","authenticated-orcid":false,"given":"Yuko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-9066","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-5515","authenticated-orcid":false,"given":"Atsushi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-2954","authenticated-orcid":false,"given":"Yuichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7775-6653","authenticated-orcid":false,"given":"Rieko","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.09.007_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nprot.2009.120","article-title":"Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications","volume":"4","author":"Abel","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jid.2021.09.007_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.09.007_bib4","first-page":"519","article-title":"Comprehensive genomic characterization of squamous cell lung cancers [published correction appears in Nature 2012;491:288]","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.09.007_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, Brigham and Women\u2019s Hospital, Broad Institute, Brown University","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.09.007_bib6","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/ijms21114098","article-title":"p53-PHLDA3-Akt network: the key regulators of neuroendocrine tumorigenesis","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib7","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1111\/cas.13796","article-title":"PHLDA1, another PHLDA family protein that inhibits Akt","volume":"109","author":"Chen","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ccell.2016.04.004","article-title":"Squamous cell cancers: a unified perspective on biology and genetics","volume":"29","author":"Dotto","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2021.09.007_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/cas.12933","article-title":"Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells","volume":"107","author":"Ezawa","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib10","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1073\/pnas.122039999","article-title":"Placental overgrowth in mice lacking the imprinted gene Ipl","volume":"99","author":"Frank","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.09.007_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"a language for data analysisand graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comp Graph Stat"},{"key":"10.1016\/j.jid.2021.09.007_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1101\/gad.233247.113","article-title":"SOX9: a stem cell transcriptional regulator of secreted niche signaling factors","volume":"28","author":"Kadaja","year":"2014","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2021.09.007_bib12","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1038\/onc.2008.32","article-title":"p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis","volume":"27","author":"Kawase","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2021.09.007_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2008.12.002","article-title":"PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt","volume":"136","author":"Kawase","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.09.007_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(93)90461-X","article-title":"Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors","volume":"74","author":"Kemp","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.09.007_bib15","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41598-018-37707-z","article-title":"Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients","volume":"9","author":"Kojima","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.09.007_bib16","doi-asserted-by":"crossref","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","article-title":"p53 Research: the past thirty years and the next thirty years","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jid.2021.09.007_bib17","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1012720108","article-title":"Identifying the cellular origin of squamous skin tumors","volume":"108","author":"Lapouge","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.09.007_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2016.10.018","article-title":"Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition","volume":"20","author":"Latil","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2021.09.007_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2021.09.007_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrc1546","article-title":"Nature and nurture - lessons from chemical carcinogenesis","volume":"5","author":"Luch","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2021.09.007_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/ddi054","article-title":"Enamelin (Enam) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI)","volume":"14","author":"Masuya","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2021.09.007_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ceb.2017.11.005","article-title":"Deciphering p53 signaling in tumor suppression","volume":"51","author":"Mello","year":"2018","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jid.2021.09.007_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/0008-5472.CAN-08-3240","article-title":"Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma","volume":"69","author":"Moral","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.09.007_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.3878","article-title":"Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma [published correction appears in Nat Med 2016;22:217","volume":"21","author":"Nassar","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2021.09.007_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.09.007_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1349-7006.2006.00375.x","article-title":"Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis [published correction appears in Cancer Sci 2007;98:464]","volume":"98","author":"Ohki","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib27","doi-asserted-by":"crossref","first-page":"22627","DOI":"10.1074\/jbc.C000235200","article-title":"Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase","volume":"275","author":"Ohki","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.09.007_bib28","doi-asserted-by":"crossref","first-page":"E2404","DOI":"10.1073\/pnas.1319962111","article-title":"PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors","volume":"111","author":"Ohki","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.09.007_bib29","doi-asserted-by":"crossref","first-page":"a026054","DOI":"10.1101\/cshperspect.a026054","article-title":"Transcriptional regulation by wild-type and cancer-related mutant forms of p53","volume":"7","author":"Pfister","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jid.2021.09.007_bib30","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.09.007_bib31","first-page":"6615","article-title":"Alterations of the p53 tumor suppressor gene during mouse skin tumor progression","volume":"51","author":"Ruggeri","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.09.007_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187927","article-title":"Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage","volume":"12","author":"Sakata","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.09.007_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41568-018-0024-5","article-title":"Deciphering the cells of origin of squamous cell carcinomas","volume":"18","author":"S\u00e1nchez-Dan\u00e9s","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2021.09.007_bib34","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1158\/0008-5472.CAN-07-2564","article-title":"Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis","volume":"67","author":"Segrelles","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2021.09.007_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cas.14279","article-title":"Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain","volume":"111","author":"Suzuki","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ebiom.2017.05.017","article-title":"The transcriptional landscape of p53 signalling pathway","volume":"20","author":"Tanikawa","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jid.2021.09.007_bib37","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1073\/pnas.1012670108","article-title":"Defining the origins of Ras\/p53-mediated squamous cell carcinoma","volume":"108","author":"White","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.09.007_bib38","doi-asserted-by":"crossref","first-page":"12994","DOI":"10.1038\/s41598-018-31349-x","article-title":"Time-series analysis of tumorigenesis in a murine skin carcinogenesis model","volume":"8","author":"Aoto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.09.007_bib39","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/ijms21114098","article-title":"p53-PHLDA3-Akt network: the key regulators of neuroendocrine tumorigenesis","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2021.09.007_bib40","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41598-018-37707-z","article-title":"Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients","volume":"9","author":"Kojima","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.09.007_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2016.10.018","article-title":"Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition","volume":"20","author":"Latil","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jid.2021.09.007_bib42","doi-asserted-by":"crossref","first-page":"E2404","DOI":"10.1073\/pnas.1319962111","article-title":"PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors","volume":"111","author":"Ohki","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.09.007_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102111","article-title":"Meis1 regulates epidermal stem cells and is required for skin tumorigenesis","volume":"9","author":"Okumura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.09.007_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cas.14279","article-title":"Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain","volume":"111","author":"Suzuki","year":"2020","journal-title":"Cancer Sci"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21022715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21022715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:26:19Z","timestamp":1758302779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21022715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0022202X21022715"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.09.007","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PHLDA3 Is an Important Downstream Mediator of p53 in Squamous Cell Carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}